Trial Profile
Additional treatment to primary PCI: effects of ischemic postconditioning and Exenatide.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2012
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 16 Jun 2011 New trial record